CLO20-060: Factors Associated with the Uptake of Adjuvant Pertuzumab in Patients with Stage I-III HER2-positive Breast Cancer: The University of Colorado Cancer Center Experience
Authors:
Ericson Stoen
Ericson StoenUniversity of Colorado Anschutz Medical Campus, Aurora, CO